ZQY-13314-07368
2 vaccinations
1 coded response
21 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 481 / MI
- Registered
- 2022-10-01
- Relationship
- Child or adolescent in my care
- Guardian
- KEE-29528-60646
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-09-29
Dose 1 — Pfizer-BioNTechCo-administered: Flu:Hepatitis B:Hib:Other:Polio:Rotavirus:Tetanus
-
2022-10-01
Registered in v-safe
- 2022-10-01
- 2022-10-03
- 2022-10-04
- 2022-10-05
- 2022-10-06
- 2022-10-13
- 2022-10-20
-
2022-10-27
Dose 2 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-27
- 2022-10-28
- 2022-10-29
- 2022-10-31
- 2022-11-01
- 2022-11-02
- 2022-11-03
- 2022-11-10
- 2022-11-17
- 2022-11-24
- 2022-12-01
-
2022-12-08
Survey response — day 42, dose 2, under 3MedDRA: Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: She had a cold over the weekend with runny nose/congestion.MedDRA releases: 2024-11 · check-in free text available
- 2023-01-26
- 2023-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-09-29 | Pfizer-BioNTech | Flu:Hepatitis B:Hib:Other:Polio:Rotavirus:Tetanus |
| 2 | 2022-10-27 | Pfizer-BioNTech | Flu |
Free text
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: She had a cold over the weekend with runny nose/congestion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release